Migkos MP, Kaltsonoudis E, Pelechas E, Drossou V, et al. Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience. Rheumatol Int 2021;41:903-909.
PMID: 33655421